BeiGene Presents Clinical Results of Tislelizumab in Relapsed/Refractory Classical Hodgkin’s Lymphoma at the 60th American Society of Hematology Annual Meeting
Company to Host Investor Meeting and Webcast Today, December 3, at 8 pm PST BEIJING, China and CAMBRIDGE, Mass., Dec. […]